Purchase Order 75F40124P00321

The Food and Drug Administration (FDA) awarded a $245,042.83 firm-fixed-price purchase order contract to Caitta Inc., a U.S. Small Business Administration (SBA) certified 8(a) and economically disadvantaged woman-owned small business (EDWOSB), for the procurement of an Inductively Coupled Plasma Triple Quadrupole Mass Spectrometer (ICP-QQQ). This instrument will be used to support the FDA's regulatory oversight and public health mission. The contract has a completion date of November 3, 2025. Caitta Inc. is an experienced federal contractor, holding several Indefinite Delivery Vehicles with the FDA and other agencies, which have enabled the company to provide a range of scientific, technical, and administrative services to the federal government.